Status:
COMPLETED
Influence of Dexmedetomidine on a Closed-Loop Anesthesia System
Lead Sponsor:
Hopital Foch
Conditions:
Anesthesia
Eligibility:
MALE
18+ years
Phase:
PHASE3
Brief Summary
The main objective if to evaluate the sparing effect of dexmedetomidine on the doses of propofol and remifentanil.
Eligibility Criteria
Inclusion
- male patients scheduled for a general anesthesia
Exclusion
- age lower than 18 years
- allergy to propofol, or to soja or to peanuts, or to sufentanil, to remifentanil, or to morphine,or to a myorelaxant or to an excipient,
- hypersensibility to sufentanil, or to remifentanil, or to other derivate of fentanyl,
- history of central nervous system disease,
- patients receiving a psychotropic treatment or an agonist-antagonist opiate,
- hypovolemic patients,
- patients receiving a cardio-vascular treatment,
- expected bleeding surgical procedure,
- simultaneous general and loco-regional anesthesia,
- severe hepatic insufficiency.
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT00921284
Start Date
June 1 2009
End Date
July 1 2011
Last Update
September 23 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Foch
Suresnes, France, 92151